Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last?

  title={Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last?},
  author={M Bixquert Jim{\'e}nez},
  journal={Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva},
  volume={101 8},
Irritable bowel syndrome (IBS) is the most common functional digestive disorder, and may affect 11-20% of the adult population in industrialized countries. In accordance with Rome III criteria (2006) IBS involves abdominal pain and bowel habit disturbance, which are not explained by structural or biochemical abnormalities. Several hypotheses attempt to account for the pathophysiology of IBS, but the etiology still remains uncertain or obscure, perhaps multifactorial. Abnormalities in colonic… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 21 extracted citations

Irritable Bowel Syndrome : Prevalence , Type and Associated Factors among Male Adult residents at Al-Iskan Avenue in Makkah Almukarramah , Saudi Arabia

Abduljabbar M Alfetni, Ahmad H Alturkstani, +9 authors Haifa S Alhejaili
View 6 Excerpts
Highly Influenced

A double-blind, placebo-controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea-predominant IBS.

Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society • 2017

Partially Hydrolyzed Guar Gum in the Treatment of Irritable Bowel Syndrome with Constipation: Effects of Gender, Age, and Body Mass Index

Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association • 2015
View 2 Excerpts

Similar Papers

Loading similar papers…